{"id":195,"date":"2023-08-28T18:49:03","date_gmt":"2023-08-28T18:49:03","guid":{"rendered":"https:\/\/www.libertymanagement.us\/fda-news\/?p=195"},"modified":"2023-08-28T18:49:03","modified_gmt":"2023-08-28T18:49:03","slug":"medical-devices-product-classification","status":"publish","type":"post","link":"https:\/\/www.libertymanagement.us\/fda-news\/2023\/08\/28\/medical-devices-product-classification\/","title":{"rendered":"MEDICAL DEVICES PRODUCT CLASSIFICATION"},"content":{"rendered":"\n

Medical devices are categorized into different classes based on their risk level and intended use. These classifications of U.S. Food and Drug Administration (FDA) to ensure the safety and effectiveness of these devices. Below are the classification of medical devices by FDA.<\/p>\n\n\n\n

Class I: Low Risk<\/strong><\/p>\n\n\n\n

  1. These are considered low-risk devices, typically involving minimal potential harm to the user.<\/li>
  2. Examples include elastic bandages, examination gloves, and most manual surgical instruments.<\/li>
  3. General controls are sufficientto provide reasonable assurance of safety and effectiveness.<\/li><\/ol>\n\n\n\n

    Class II: Moderate Risk<\/strong><\/p>\n\n\n\n

    1. These devices have a higher level of risk than Class I devices and require greater regulatory controls.<\/li>
    2. Examples include syringes, infusion pumps, and some diagnostic tests.<\/li>
    3. Special controls, such as performance standards, post-market surveillance, and patient registries, may be necessary to ensure safety and effectiveness.<\/li><\/ol>\n\n\n\n

      Class III: High Risk<\/strong><\/p>\n\n\n\n

      1. Class III devices pose the highest level of risk to patients and usually support or sustain human life, are implanted, or present potential unreasonable risk of illness or injury.<\/li>
      2. Examples include implantable pacemakers, heart valves, and automated external defibrillators.<\/li>
      3. These devices require pre-market approval (PMA) applications to demonstrate their safety and efficacy.<\/li><\/ol>\n\n\n\n

        Before marketing a medical device, manufacturers must ensure they comply\nwith the relevant regulatory requirements for the intended market. This might\ninvolve submitting various documentation, conducting testing, and obtaining the\nappropriate approvals or clearances from regulatory agencies.<\/p>\n\n\n\n

        Liberty Management Group<\/a>, a leading FDA consulting group in the United States provides assistance with classification of devices and establishment registration<\/a>, device listing, medical device label review, UDI listings<\/a> and US agent service<\/a> for foreign drug establishment firms.<\/p>\n\n\n\n

        Sudha S<\/p>\n\n\n\n

        Regulatory Consultant<\/p>\n\n\n\n

        Email: office@libertymanagement.us<\/p>\n\n\n\n

        www.fdahelp.us<\/p>\n","protected":false},"excerpt":{"rendered":"

        Medical devices are categorized into different classes based on their risk level and intended use. These classifications of U.S. Food and Drug Administration (FDA) to ensure the safety and effectiveness of these devices. Below are the classification of medical devices by FDA. Class I: Low Risk These are considered low-risk devices, typically involving minimal potential … Continue reading “MEDICAL DEVICES PRODUCT CLASSIFICATION”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[27],"tags":[5],"class_list":["post-195","post","type-post","status-publish","format-standard","hentry","category-fda-registration-medical-device","tag-fda-medical-devices-classification"],"_links":{"self":[{"href":"https:\/\/www.libertymanagement.us\/fda-news\/wp-json\/wp\/v2\/posts\/195","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.libertymanagement.us\/fda-news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.libertymanagement.us\/fda-news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.libertymanagement.us\/fda-news\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.libertymanagement.us\/fda-news\/wp-json\/wp\/v2\/comments?post=195"}],"version-history":[{"count":1,"href":"https:\/\/www.libertymanagement.us\/fda-news\/wp-json\/wp\/v2\/posts\/195\/revisions"}],"predecessor-version":[{"id":196,"href":"https:\/\/www.libertymanagement.us\/fda-news\/wp-json\/wp\/v2\/posts\/195\/revisions\/196"}],"wp:attachment":[{"href":"https:\/\/www.libertymanagement.us\/fda-news\/wp-json\/wp\/v2\/media?parent=195"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.libertymanagement.us\/fda-news\/wp-json\/wp\/v2\/categories?post=195"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.libertymanagement.us\/fda-news\/wp-json\/wp\/v2\/tags?post=195"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}